Andrew C Harris MD
Associate Attending - Memorial Sloan Kettering Cancer Center
Request Appointment
530 East 74th StreetNew York, NY 10021
Overview of Dr. Harris
Dr. Andrew Harris is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Primary Children's Hospital. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 12 years. He is one of 50 doctors at Primary Children's Hospital and one of 97 doctors at Memorial Sloan Kettering Cancer Center who specialize in Pediatric Hematology & Oncology. He has more than 70 publications and over 500 citings.
Education & Training
University of MichiganFellowship, Pediatric Hematology/Oncology, 2008 - 2011
Cleveland Clinic FoundationResidency, Pediatrics, 2005 - 2008
Case Western Reserve University School of MedicineClass of 2005
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2021 - 2026
UT State Medical License 2015 - 2022
MI State Medical License 2008 - 2018
OH State Medical License 2005 - 2008
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.Gabrielle Meyers, Mehdi Hamadani, Michael Martens, Haris Ali, Patrice Chevallier
Bone Marrow Transplantation. 2025-02-27 - The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2025-02-01 - Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...Neel S Bhatt, Andrew C Harris, Lev Gorfinkel, Katarzyna Ibanez, Eric R Tkaczyk
Transplantation and Cellular Therapy. 2025-02-01
Abstracts/Posters
- A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...Andrew C Harris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...Andrew C. Harris, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Grant Support
- Effects of maternal e-cigarette aerosol exposure on nicotine's addiction-related behavioral and neurobiological effects in offspringHENNEPIN HEALTHCARE RESEARCH INSTITUTE2025–2029
- Comparative neurobehavioral pharmacology of combusted and non-combusted tobacco productsHENNEPIN HEALTHCARE RESEARCH INSTITUTE2020–2025
- Identifying genomic loci related to vulnerability to opioid addictionARIZONA STATE UNIVERSITY-TEMPE CAMPUS2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
